We have located links that may give you full text access.
The effects of scapulothoracic bursa injections in patients with scapular pain: a pilot study.
Archives of Physical Medicine and Rehabilitation 2009 Februrary
OBJECTIVE: To assess the effects of steroid plus hyaluronate injections for scapulothoracic bursitis in patients with scapular pain.
DESIGN: Prospective open-label unicenter trial with a 3-month follow-up.
SETTING: University rehabilitation hospital.
PARTICIPANTS: Twenty-two cases of suspected scapulothoracic bursitis.
INTERVENTION: Injections into scapulothoracic bursa were performed with steroid plus hyaluronate. Injections were administered once a week for 3 weeks.
MAIN OUTCOME MEASURES: Visual analog scale (VAS), Rubin scale, adverse events, and injection-associated complications.
RESULTS: Mean outcome scores at 3-month follow-up visits showed significant improvements versus baseline (mean VAS increased from 7.8 to 2.2) (P<.05). Furthermore, mean VAS scores at 1, 2, and 3 weeks after treatment commencement showed significant improvements versus baseline (P<.05). No serious complication occurred during the study.
CONCLUSIONS: Scapulothoracic bursitis should be considered when treating patients with perimarginal scapular pain or subscapular pain. Our findings show that steroid plus hyaluronate injections into the scapulothoracic bursa provide an effective means of treating patients with scapulothoracic bursitis.
DESIGN: Prospective open-label unicenter trial with a 3-month follow-up.
SETTING: University rehabilitation hospital.
PARTICIPANTS: Twenty-two cases of suspected scapulothoracic bursitis.
INTERVENTION: Injections into scapulothoracic bursa were performed with steroid plus hyaluronate. Injections were administered once a week for 3 weeks.
MAIN OUTCOME MEASURES: Visual analog scale (VAS), Rubin scale, adverse events, and injection-associated complications.
RESULTS: Mean outcome scores at 3-month follow-up visits showed significant improvements versus baseline (mean VAS increased from 7.8 to 2.2) (P<.05). Furthermore, mean VAS scores at 1, 2, and 3 weeks after treatment commencement showed significant improvements versus baseline (P<.05). No serious complication occurred during the study.
CONCLUSIONS: Scapulothoracic bursitis should be considered when treating patients with perimarginal scapular pain or subscapular pain. Our findings show that steroid plus hyaluronate injections into the scapulothoracic bursa provide an effective means of treating patients with scapulothoracic bursitis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app